TenderlineUK
Procurement Intelligence
Search
Find a TenderAwarded
Published 12 May 2021, 22:55 BST

Official UK procurement notice

Diagnostic Service Solutions · UK public procurement notice

Official notice

Authority: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (“UHCW”) (NHS & healthcare)·Consortium: 2 public authorities

Framework agreement5 lotsServicesOpen procedureMax 5 lots per supplier
Sectors: Health & Social Care (85) Delivery: UK
Framework ceiling (notional)£260,000,000total for 5 lots · framework ceiling, not attributable revenue · 1 value update
Submissions closed 11 Feb 2022awarded 23 Feb 2022
Lots 5max 5 won per supplier

What is being bought5 lots · detail below

Published requirement description

The tender is to establish a Framework Agreement for the supply of Diagnostic Service Solutions, which allows access for outsourcing reporting services for the benefit of the Public Sector Healthcare Organisations (“the Participating Authority(s)”). The agreement will be split into 4 lots:

Lot 1 - Radiology Reporting

Lot 2 - Pathology Reporting

Lot 3 - Pathology Referral Testing

Lot 4 - Mobile Diagnostic Imaging

The duration of the framework agreement will be 4 years maximum, 2 years initial period, with the option

to extend for up to 24 months.

CPV: Dermatology services · Diagnostic devices · Diagnostic supplies · Diagnostic ultrasound devices · Diagnostics and radiodiagnostic devices and supplies · Health and social work services · Hospital and related services · Hospital services · Medical imaging services · Medical practice services · Pathology services · Radiology film · +1 more

How this framework works

From the published notice
Bids received
14 bids on the busiest of 4 lots · 33 suppliers appointed

Lots and requirements (5)Procurement structure

5 lots · 4 with a published value · win at most 5 of them · same evaluation weights on every lot

Every one of these 2 lots carries the same published figure, £50,000,000: it is the framework's maximum for the whole notice, not each lot's own budget, and no share per lot is published. The cards below say ceiling above rather than repeat it.

Lot #1Radiology ReportingCancelledRenewalPublished value£100,000,000

HTE established a framework agreement for the supply of Diagnostic Service Solutions, which allows access for outsourcing reporting services for the benefit of the Public Sector Healthcare Organisations (“the Participating Authority(s)”). The agreement currently splits into 4 lots:

Lot 1: Radiology Reporting

Lot 2: Pathology Reporting

Lot 3: Pathology Referral Testing

Lot 4: Mobile Diagnostic Imaging

Delivery: UK
Extensions: Option to extend up to a further 24 months.Variant bids: not allowed
85111000 Hospital services85111800 Pathology services85150000 Medical imaging services
Lot #2Pathology ReportingCancelledRenewalceiling above

The Tender is to establish a framework agreement for all outsource Dianostics services this includes Pathology Reporting. This covers all specimen types for diagnostic purposes, including the provision of logistics to collect specimens as required and provision of the diagnostic report, including connection into the relevant systems as required.

Delivery: UK
Extensions: Option to extend up to a further 24 months.Variant bids: not allowed
85111800 Pathology services
Lot #3Referral TestingCancelledRenewalPublished value£60,000,000

The Tender is to establish a framework agreement for all outsource Dianostics services this includes Referral Testing. Laboratory testing of any sample, this may include routine esoteric, toxicology, genetic and any other type of test.

Transport is to be provided.

I.T integration where required.

Delivery: UK
Extensions: Option to extend up to a further 24 months.Variant bids: not allowed
85111000 Hospital services
Lot #4Mobile Diagnostic ImagingCancelledRenewalceiling above

The Tender is to establish a framework agreement for all outsource Dianostics services this includes Mobile Diagnostic Imaging. The provision of all temporary mobile imaging equipment facilities for all modalities on customer sites outside of the main hospital departments. Diagnostic reporting should be included if required. Staffing needs to be included. Servicing and maintenance to be included.

Delivery: UK
Extensions: Option to extend up to a further 24 months.Variant bids: not allowed
85111000 Hospital services
Lot #5Mobile Diagnostic ImagingPlannedLot estimate not published

This Lot is for the provision of all temporary mobile imaging equipment facilities for all modalities on customer sites outside of the main hospital departments. This may include mobile endoscopy.

Delivery: UK
32354100 Radiology film33124000 Diagnostics and radiodiagnostic devices and supplies33124100 Diagnostic devices33124120 Diagnostic ultrasound devices33124130 Diagnostic supplies85110000 Hospital and related services

What it takes to win
i

How this buyer will score bids.

The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).

Evaluation split and conditions of participation as published; the tender pack may add more
How bids were scored · same split on all 4 lots
Quality: 60Price: 140
Published sub-criteria (3)
  • Technical: 60
  • Price: 40
  • price: 100
Published award criteria (3)
  • Technical: 60%
  • Price: 40%
  • Price: 100%
What this means for your bid
  • Price carries 140 of 200 points: a 10% discount moves about 14 points. This one is won on the number: sharpen the price before polishing the prose.
  • “Diagnostic Service Solutions” is a framework: the contest is a place on its panel, not a single contract.

Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.

Procedure terms & legal framework

From the official record · publisher note attached
Procedure method
Open procedure
Legal basis
CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
Procurement category
Services
Notice status
Awarded
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Framework agreement
Who may use this agreement
Not stated in the notice; call-off rights may be limited to the establishing authority
Competition type
Competitive procedure
GPA / WTO covered
Yes (GPA)
Recurring procurement
No (one-off requirement)
First published
12 May 2021, 22:55 BST
Last source update
30 Jul 2026, 09:40 BST
Award evaluation window
14 Feb 2022 – …
FTS notice number
2026/S 000-072007
Classification (CPV)
Dermatology servicesDiagnostic devicesDiagnostic suppliesDiagnostic ultrasound devicesDiagnostics and radiodiagnostic devices and suppliesHealth and social work servicesHospital and related servicesHospital servicesMedical imaging servicesMedical practice services
+3 morePathology servicesRadiology film
Delivery area
UK
Official registry OCID
ocds-h6vhtk-02b066 Find a Tender
Review and risk notes
Review procedure

HTE will incorporate a standstill period at the point information on the award of the contract is communicated to tenderers. That notification will provide full information on the award decision. The standstill period, which will be for a minimum of 10 calendar days, provides time for unsuccessful tenderers to challenge the award decision before the contract is entered into.

Publisher note: HTE is a central purchasing body who is able to carry out this tender exercise by virtue of its appointment as an agent of UHCW. Notwithstanding HTE’s relationship with UHCW, it is HTE conducting this tender exercise and will execute the resultant framework agreement with successful bidders. The bodies to whom the use of this framework agreement will be open include all contracting authorities in the UK as defined in Regulation 2 of the Public Contracts Regulations 2015 as may be updated from time to time. In particular, the following entities in the UK (particularly those of a health and/or social care nature) are envisaged as framework agreement users: (1) All National Health Service (NHS) bodies in England, including but not limited to (i) acute trusts (as listed at: http://www.nhs.uk/servicedirectories/pages/acutetrustlisting.aspx); (ii) health and care trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx); (iii) mental health trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/MentalHealthTrustListing.aspx); (iv) clinical commissioning groups (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CCGListing.aspx); (v) ambulance trusts (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/CareTrustListing.aspx (vi) area teams (as listed at: http://www.nhs.uk/ServiceDirectories/Pages/AreaTeamListing.aspx); (vii) special health authorities http://www.nhs.uk/ServiceDirectories/Pages/SpecialHealthAuthorityListing.aspx); (viii) NHS England; and (ix) clinical senates and strategic clinical networks. (2) All NHS bodies in Wales, including but not limited to all (i) health boards; (ii) NHS trusts; (iii) the national delivery group; (iv) community health councils; and (v) NHS Wales shared services partnership (as listed at http://www.wales.nhs.uk/nhswalesaboutus/structure. (3) All NHS bodies in Northern Ireland (known as Health & Social Care), including but not limited to:(i) health and social care trusts (as listed at: http://online.hscni.net/?s=Trust (ii) health agencies (as listed at: http://online.hscni.net/?s=health+agencies (iii) hospitals (as listed at: http://online.hscni.net/?s=hospitals; and (iv) the Health and Social Care Board. (4) Social enterprises undertaking some or all of the previous service provider functions of contracting authorities in relation to health and/or social care services (including charitable incorporated organisations, cooperatives, industrial and provident societies and community interest companies listed on the Companies House WebCheck service). (5) Ministerial departments and non-ministerial departments of central government, non-departmental agencies and other public bodies, and public corporations (as listed at: https://www.gov.uk/government/organisations). (6) Devolved governmental and parliamentary organisations within the UK, including but not limited to the Scottish Government, Scottish Parliament, and Scottish public bodies (as listed at: http://www.scotland.gov.uk/Topics/Government/public-bodies/about/Bodies), as well as the Welsh Government, Welsh Assembly and Welsh unitary authorities (as listed at: http://www.assembly.wales/en/abthome/role-of-assembly-how-it- works/Pages/governance-of-wales.aspx (7) All local authorities (as listed at: http://local.direct.gov.uk/LDGRedirect/Start.do?mode=1) (8) The Ministry of Defence (as detailed at:https://www.gov.uk/government/organisations/ministry-of-defence). This list includes each organisation’s successors and assigns, any equivalent organisations and associated organisation created due to any organisational changes. This framework agreement will be open to any bodies or organisations operating in the UK of a health, and/or social care nature or which have a similar procurement need, and/or any UK based central government authority listed at Annex I of Directive 2014/24/EU, in respect of any goods or services to any of the above listed organisation.

How it was run

Official notice
Run through: Jaggaer · Who buys & how to bid on JAGGAER
Supplier login requiredLanguage: EN
Access & registration note: Free; latest Chrome/Edge/Firefox only — corporate browsers fail
Appointment period ends
11 Feb 2022, 14:00 GMT
Submission channel
{"electronicSubmission","written"}
Accepted languages
en
Bid validity
180 days from the deadline
Bids opened
14 Feb 2022, 09:00 GMT
Detailed submission instructions & authority contactsFrom official release

healthtrusteurope.bravosolution.co.uk ↗

Timeline

31 Aug 2021 → 30 Jul 2026 · 4 dates
  1. Next notice expected
    31 Aug 2021, 00:00 BST
  2. Admission / appointment period endsperiod end, not a bid countdown
    11 Feb 2022, 14:00 GMT
  3. Bids opened
    14 Feb 2022, 09:00 GMT
  4. Notice published82 days ago
    30 Jul 2026, 09:40 BST

Notice history

6 events · 4 releases on Find a Tender · since 7 Jan 2022
  1. Published value updated to £260,000,000
    7 Jan 2022, 22:45 GMT
    was £100,000,000
  2. Status changed to active
    7 Jan 2022, 22:45 GMT
  3. Procurement method changed
    7 Jan 2022, 22:45 GMT
  4. Deadline published: 11 Feb 2022, 14:00 GMT
    7 Jan 2022, 22:45 GMT
  5. Status changed to complete
    11 Oct 2022, 15:09 BST
  6. Buyer details updated
    30 Jul 2026, 09:40 BST
Routine re-releases (4)
  • 2021-05: 1 release · 12 May 2021

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Suppliers appointed 33admitted to the panel · see the list ↓
Bids received 14busiest of 4 lots
Contracts signed 5latest 23 Feb 2022

5 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.

Contracts

All 4 of these contracts carry the same published figure, £65,000,000, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.

  • Radiology Reporting

    Signed
    23 Feb 2022
    Value
    ceiling above
    Status
    active

  • Pathology Reporting

    Signed
    23 Feb 2022
    Value
    ceiling above
    Status
    active

  • Pathology Referral Testing

    Signed
    23 Feb 2022
    Value
    ceiling above
    Status
    active

  • Mobile Diagnostic Imaging

    Signed
    23 Feb 2022
    Value
    ceiling above
    Status
    active

  • Diagnostic Service Solutions

    Signed
    23 Feb 2022
    Value
    £260,000,000
    Status
    active
    • Change The initial length of contract was 48 months. This modification is to extend the contract for an additional 5 months making it a total of 53 months. The total value remains at £260,000,000., Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee: This modification is made in accordance with Regulation 72(1)(e) (non substantial modification) and Regulation 72(1)(c) (unforeseen circumstances) of the Public Contracts Regulations 2015. The modification relates to an extension of the term of the existing framework agreement by 5 months. The extension does not involve any change to the scope, nature or original design of the framework, nor does it introduce any new requirements or contractual terms. There is no material change to the economic balance of the framework in favour of participating suppliers. The modification is therefore considered to be non substantial for the purposes of Regulation 72(1)(e). The need for the extension arises from circumstances which could not reasonably have been foreseen at the time the framework was established, including operational and market factors affecting the continued availability of compliant procurement routes. Without an extension to the framework, contracting authorities would be exposed to a risk of disruption and inefficiency in meeting ongoing requirements. A change of contractor, or allowing the framework to lapse without extension, would give rise to significant inconvenience and duplication of cost. Contracting authorities would be required to make alternative interim arrangements, resulting in additional administrative burden, increased cost and potential delay. Suppliers would likewise incur unnecessary and duplicative costs, and there would be an increased risk of fragmented procurement activity. In addition, certain suppliers would be unable to access the market in the absence of a compliant procurement route, resulting in suppliers being effectively locked out and a restriction on lawful market access. The extension is limited to a period of 5 months only, does not alter the overall competitive position of the framework, and is not intended to avoid or delay competition. The modification ensures continuity and stability for public bodies while maintaining existing market access arrangements on the terms originally established. For these reasons, the modification is permitted under Regulation 72(1)(e) and Regulation 72(1)(c) and is published by way of this modification notice in accordance with the transparency requirements of the Regulations.

Bid statistics published by the authority

LotBidsSMEVCSEValid bid range
1 · Radiology Reporting14bids———
2 · Pathology Reporting7bids———
3 · Referral Testing6bids———
4 · Mobile Diagnostic Imaging11bids———

Contracting authority & participating public bodies

2 public bodies on the notice

HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (“UHCW”)

Contracting authorityNHS & healthcareBody governed by public lawHealth OC358224 19 George Road, Edgbaston, Birmingham, UK, B15 1NUContact name, email, phone Published organisation website ↗

Framework contractors & participating bidders

79 commercial parties on the notice · 50 awarded

The first 50 of 79 commercial parties (by name); the JSON mirror lists them all.

Show 40 more suppliers

Official documents & specifications (2)

Official links; attachments are not copied

Tender pack and attachments

  • Economic and financial selection criteriatenderEconomic and financial selection criteria
  • Technical selection criteriatenderTechnical selection criteria